We are proud to announce that Telos PGX has been awarded the Fastest-Growing Laboratory Testing Company in Texas for 2024 by Best of Best Review. This prestigious recognition highlights Telos PGX's exceptional growth and leadership in the field of pharmacogenetics, particularly in nursing home care. The company's commitment to providing cutting-edge genetic testing and its ability to meet the growing demand for personalized medicine has solidified its position as a trailblazer in the healthcare industry.

A Leader in Pharmacogenetics

Founded by visionary CEO D.J. Hart, Telos PGX stands at the forefront of personalized healthcare solutions, specializing in pharmacogenetic testing. Their unique focus on genetic testing that guides medication management has revolutionized patient care in skilled nursing facilities (SNFs) across Texas. This award emphasizes their ability to scale operations while maintaining the highest standards of accuracy, innovation, and patient care.

Telos PGX’s rapid growth is a testament to its dedication to improving clinical outcomes by reducing adverse drug reactions and supporting SNFs in meeting crucial regulatory requirements. Their partnership with SNFs ensures that residents receive the best possible care, with treatments tailored to their genetic profiles, ultimately improving their quality of life.

Why Telos PGX Stands Out

Telos PGX’s meteoric rise can be attributed to several key factors that set them apart from competitors:

• Specialization in Pharmacogenetics: As one of only two labs in the U.S. dedicated to pharmacogenetic testing, Telos PGX is unmatched in its expertise. This specialization allows them to provide the highest level of precision and innovation, helping healthcare providers make informed decisions.

• Improvement of Patient Outcomes: Through pharmacogenetic testing, Telos PGX helps clinicians optimize medication regimens, reducing the risk of adverse drug reactions and hospital readmissions, which is especially critical in nursing home populations.

• Regulatory Support for Skilled Nursing Facilities (SNFs): Telos PGX’s services are aligned with Texas’s Quality Incentive Payment Program (QIPP) metrics, supporting SNFs in meeting CMS and HHSC standards, including the reduction of antipsychotic medications and documentation of resident mobility.

• Cutting-Edge Technology: Constantly updating their testing panels with FDA-approved drug-gene interactions, Telos PGX ensures that their partner facilities are equipped with the latest and most actionable data.

• Educational Commitment: Telos PGX doesn’t stop at testing; they empower healthcare professionals with the knowledge and tools needed to incorporate pharmacogenetics into everyday clinical practice, providing ongoing support and education to ensure the best outcomes for patients.

Transforming Nursing Home Care in Texas

Telos PGX is not only the fastest-growing laboratory testing company in Texas but also a true game-changer in the healthcare industry. Their cutting-edge pharmacogenetic testing services are revolutionizing the way nursing homes approach medication management, resulting in better outcomes for elderly residents. By focusing on personalized treatment plans based on genetic profiles, Telos PGX has reduced unnecessary hospitalizations and adverse reactions, significantly elevating the standard of care in long-term facilities.

“Receiving the Fastest-Growing Laboratory Testing Company in Texas for 2024 award is a great honor and reflects the hard work of our team to provide personalized, safe, and effective treatment options for nursing home residents,” said D.J. Hart, CEO of Telos PGX. “Our mission is to empower healthcare providers with the tools and data they need to deliver the highest quality of care. We are proud of our growth and excited about the future of pharmacogenetics.”

The Telos PGX Advantage

Nursing homes across Texas choose Telos PGX for a variety of reasons:

• Exclusive Focus on Pharmacogenetic Testing

• Proven Impact on Clinical Outcomes

• Regulatory Support for SNFs to Meet QIPP Standards

• Reduction of Hospital Readmissions and Adverse Drug Events

• Continued Innovation and Commitment to Quality

Telos PGX’s dedication to excellence in personalized medicine has propelled them to the top of the industry, and they show no signs of slowing down. Their focus on pharmacogenetics is not only transforming nursing home care but also setting a new gold standard for laboratory testing across the state.

For more information about Telos PGX and their award-winning services, visit www.telospgx.com. Connect with them on Facebook and LinkedIn to stay informed on their latest innovations in pharmacogenetics and personalized medicine.